green
Positive treatment
Quoted verbatim 1×
4.2 score
G Cite
Treatment trajectory · 1997 → 2026 · click a year to view as-of
1997
2011
2026
Top citers, strongest first. 9 distinct citers.
examined
Cited as authority (quoted)
Falconer v. Penn Maritime, Inc.
the fact that the payer of damages and the dispenser of a collateral benefit are one and the same, or that they are linked in some economically meaningful sense, tends to make the deployment of the collateral source rule less attractive.
discussed
Cited "see"
North American Natural Resources, Inc. v. Strand
See Freehold Cogeneration Assoc., L.P. v. Board of Regulatory Commissioners of New Jersey, 44 F.3d 1178, 1193 (3rd Cir.1995), ce rt. denied sub nom., Jersey Central Power & Light Co. v. Freehold Cogeneration Assoc., L.P., 516 U.S. 815 , 116 S.Ct. 68 , 133 L.Ed.2d 29 (1995), but see Agrilectric Power Partners, Ltd. v. Entergy Gulf States, Inc., 207 F.3d 301 (5th Cir.2000) (citing the district court’s opinion in the instant case for the proposition that the “regulatory-out clauses” are enforceable).
cited
Cited "see"
Toro v. Sanchez
See, Lussier v. Runyon, 50 F.3d 1103, 1108-09 (1st Cir.1995) cert. denied 516 U.S. 815 , 116 S.Ct. 69 , 133 L.Ed.2d 30 (1995); Quint v. A.E.
discussed
Cited "see"
Wheat v. Sofamor, S.N.C.
See Michael v. Shiley, 46 F.3d 1316, 1335 (3rd Cir.1995), cert. denied, 516 U.S. 815 , 116 S.Ct. 67 , 133 *1365 L.Ed.2d 29 (1995) (fraudulent advertising and promotion claim survived motion for summary judgment); Hawkins v. Upjohn Co., 890 F.Supp. 609 (E.D.Tex.1994) (motion to dismiss denied where plaintiff alleged FDA relied on defendant’s representations and plaintiffs relied on FDA’s assessment).
cited
Cited "see"
Dunlap v. Medtronic, Inc.
See, Michael v. Shiley, Inc., 46 F.3d 1316 (3d Cir.), cert. denied, 516 U.S. 815 , 116 S.Ct. 67 , 133 L.Ed.2d 29 (1995); Klein v. Biscup, 109 Ohio App.3d 855 , 673 N.E.2d 225 (1996). 6 .
cited
Cited "see"
Moran v. GTech Corp.
See Lussier v. Runyon, 50 F.3d 1103, 1107-08 (1st Cir.), cert. denied, 516 U.S. 815 , 116 S.Ct. 69 , 133 L.Ed.2d 30 (1995).
discussed
Cited "see, e.g."
Brown v. DePuy Spine, Inc.
See, e.g., Michael v. Shiley, Inc., 46 F.3d 1316, 1325-27 (3d Cir.), cert. den., 516 U.S. 815 (1995) (enforcement of statement on FDA-approved label involves voluntary commitment and in any event, amounts to parallel requirement); Mitchell v. Collagen Corp., 126 F.3d at 915 (express warranty claim arises from representations of the parties made basis of the bargain between them and does not necessarily interfere with operation of the PMA); Steele v. DePuy Orthopedics, Inc., 295 F.Sup.2d 439, 456 (D.N.J. 2003) (claim that device does not conform to statements in FDA-approved materials involves …
discussed
Cited "see, e.g."
Allen W. Rose v. Hartford Underwriters Insurance Company
See, e.g., Lussier v. Runyon, 50 F.3d 1103, 1114 (1st Cir.) (holding that district court erred when it took judicial notice without giving parties an opportunity to be heard), cert. denied, 516 U.S. 815 , 116 S.Ct. 69 , 133 L.Ed.2d 30 (1995).
discussed
Cited "see, e.g."
Worthy v. Collagen Corp.
See also Michael v. Shiley, Inc., 46 F.3d 1316, 1324 (3d Cir.), cert. denied, 516 U.S. 815 , 116 S.Ct. 67 , 133 L.Ed.2d 29 (1995); Martello v. Ciba Vision Corp., 42 F.3d 1167, 1169 (8th Cir.1994), cert. denied, 515 U.S. 1161 , 115 S.Ct. 2614 , 132 L.Ed.2d 857 (1995); Stamps v. Collagen Corp., 984 F.2d 1416 , 1422-1423 & n. 3, 1424 n. 8 (5th Cir.1993); King v. Collagen Corp., 983 F.2d 1130, 1134 (1st Cir.), cert. denied, 510 U.S. 824 , 114 S.Ct. 84 , 126 L.Ed.2d 52 (1993) (all pre- Medtronic cases).
Braswell
v.
United States
v.
United States
No. 94-1981.
Supreme Court of the United States.
Oct 2, 1995.
C. A. 4th Cir. Certiorari denied.